Xiaoxia Yang, Pengfei Shang, Bingfang Yu, Qiuyang Jin, Jing Liao, Lei Wang, . . . Xiuli Guo. (2021). Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway. Elsevier.
Chicago Style (17th ed.) CitationXiaoxia Yang, Pengfei Shang, Bingfang Yu, Qiuyang Jin, Jing Liao, Lei Wang, Jianbo Ji, and Xiuli Guo. Combination Therapy with MiR34a and Doxorubicin Synergistically Inhibits Dox-resistant Breast Cancer Progression via Down-regulation of Snail Through Suppressing Notch/NF-κB and RAS/RAF/MEK/ERK Signaling Pathway. Elsevier, 2021.
MLA (9th ed.) CitationXiaoxia Yang, et al. Combination Therapy with MiR34a and Doxorubicin Synergistically Inhibits Dox-resistant Breast Cancer Progression via Down-regulation of Snail Through Suppressing Notch/NF-κB and RAS/RAF/MEK/ERK Signaling Pathway. Elsevier, 2021.